📰 Efficacy Endpoint News
Efficacy Endpoint News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Efficacy Endpoint. Real-time updates on events, politics, business and more.
May 31, 2023
FinancialContent fully hosted finance channel
August 16, 2022
DGAP-News: Formycon AG / Key word(s): Study results/Study Formycons Biosimilar Ustekinumab Candidate FYB202 Shows Comparable Efficac...
August 16, 2022
DGAP-News: Formycon AG / Key word(s): Study results/StudyFormycon's Biosimilar Ustekinumab Candidate FYB202 Shows Comparable Efficacy to Reference Product Stelara®* in Phase III Study 16.08.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release // August 16, 202...
August 16, 2022
16.08.2022 - DGAP-News: Formycon AG / Key word(s): Study results/Study Formycons Biosimilar Ustekinumab Candidate FYB202 Shows Comparable Efficacy to Reference Product Stelara* in Phase III Study 16.08.2022 / 07:30 CET/CEST The issuer is solely responsible ... Seite 1
December 15, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating...
December 15, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating...
December 15, 2021
DUBLIN, Dec. 15, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating the safety